Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurotrophin production enhancement refers to the upregulation or increased synthesis and secretion of neurotrophins—key proteins that support the growth, survival, differentiation, and function of neurons. The main neurotrophins in mammals are nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4). Enhancing their production is a therapeutic target for various neurological conditions due to their critical roles in neural development, synaptic plasticity, learning, memory, and neuronal repair.
Stimulation of neurotrophin synthesis and secretion via various mechanisms (e.g., activation of Trk receptors, modulation of intracellular signaling pathways like MAPK, PI3K/Akt, PLCγ1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurotrophin Production Enhancement.